An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Medical clinics in the western Bay of Plenty area are experiencing a spike in people presenting with influenza and Covid-19 ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

PRN02047 To: integrated care boards – chief executives GP practices community pharmacies primary care networks NHS trusts – chief executives local government chief executives health and justice ...

Australia's vaccination rates against COVID and influenza are below ideal figures, but could a future innovation be able to ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

Solid phase III efficacy results for Moderna Inc.’s seasonal influenza vaccine, mRNA-1010, may lead the company to resubmit a ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

Monitoring fungal spores in the outdoor air can predict surges in flu and COVID-19 infections, especially during the fall, ...

Many of the protections and behaviours that helped us during the pandemic — like staying home when sick, wearing masks, and ...